Implementing community pharmacy-based influenza point-of-care test-and-treat under collaborative practice agreement.

ABSTRACT:

Background

Early and accessible testing for influenza with point-of-care testing (POCT) can be a critical factor for deciding to begin antiviral treatment. More than 10,000 pharmacies across the USA offer Clinical Laboratory Improvement Amendments-waived POCT for infectious diseases, such as influenza A/B. Knowledge of barriers and facilitators to large-scale POCT implementation may be useful in scaling POCT for influenza test-and-treat services (Flu POCT). The objective of this study was to explore the experiences of pharmacists who were early adopters of Flu POCT and treatment under collaborative practice agreement in community pharmacy settings.

Methods

Qualitative research design with in-depth, semi-structured virtual video interviews of licensed US community pharmacists

SUBMITTER: Hohmeier KC 

PROVIDER: S-EPMC9287716 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature